20
Participants
Start Date
September 18, 2024
Primary Completion Date
May 31, 2027
Study Completion Date
May 31, 2027
NS-050/NCNP-03
NS-050/NCNP-03 solution for IV infusion.
Placebo
NS-050/NCNP-03 placebo-matching solution for IV infusion.
RECRUITING
University of Pittsburgh Medical Center, Pittsburgh
RECRUITING
Children's Hospital of Philadelphia, Philadelphia
RECRUITING
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RECRUITING
University of Kansas Medical Center, Kansas City
RECRUITING
Children's Hospital Colorado, Aurora
NOT_YET_RECRUITING
Children's Hospital Los Angeles, Los Angeles
NOT_YET_RECRUITING
Alberta Children's Hospital, Calgary
NOT_YET_RECRUITING
British Columbia Children's Hospital, Vancouver
RECRUITING
London Health Sciences Centre, London
RECRUITING
Pusan National University Yangsan Hospital, Yangsan
NOT_YET_RECRUITING
Seoul National University Hospital, Seoul
NOT_YET_RECRUITING
Ankara Bilkent City Hospital, Ankara
NOT_YET_RECRUITING
Istanbul University, Istanbul
NOT_YET_RECRUITING
Yeditepe University Kosuyolu Hospital, Istanbul
RECRUITING
National Hospital Organization Nagara Medical Center, Nagara
RECRUITING
Hyogo Medical University Hospital, Nishinomiya
RECRUITING
NHO Osaka Toneyama Medical Center, Toyonaka
RECRUITING
National Center of Neurology and Psychiatry, Kodaira
Lead Sponsor
Collaborators (1)
Nippon Shinyaku Co., Ltd.
INDUSTRY
NS Pharma, Inc.
INDUSTRY